rikkiGreat posting for your fans on HC imoVery early in game -...

First 45 Last

Share
Profile

Follow
Merchant2000

20,601 Posts.

869

20/10/20

08:35

Post #: 48221068
Share

Originally posted by rikki: ↑

Correct Q they are certainly adding value:

By the end of Q1 next CY (2021), Kazia will have its drug:

• In 5 different clinical trials for 4 different indications
• Have completed 1 trial for its core indication,
• Completed 1 trial in an indication of high unmet clinical need,
• Started 1 trial in a new indication, and
• Started their drug in a pivotal trial that could lead to its approval.

That is a very full list of clinical activities.

And we are already heavily awarded by the FDA:

Paxalisib has been granted orphan drug designation (ODD) and Fast Track Designation (FTD) for GBM.

For DIPG, it has been granted ODD and Rare Paediatric Disease Designation (RPDD).

All of these designations aim to do the same thing and that is to make it as easy as possible for a company to produce

(A) the best quality clinical trial data to support its development candidates,
(B) the right data to support FDA approval,
(C) a high quality New Drug Application (NDA).

Where possible and within the FDAs rules and requirements, the FDA will provide incentives, such as shortened review times, market exclusivity and the possibility ofa Priority Review Voucher (PRV) for those with RPDD.

we are headed for a PRV with DPiG - this looks to be the desire given comments James has made.

though our GBM trial is already paid for... maybe it’s use will be fir drug 3!

Expand

rikki
Great posting for your fans on HC
imo
Very early in game - market cap versus cash raised since 2015 !!!!!!

Research Quality of life with OS and PFS

and cost of treatment to patients etc

KZA Price at posting: 81.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

RCE

Recce's R327 found effective against E.coli during clinical trial

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

There are more pages in this discussion • 18 more messages in this thread...

First 45 Last

Add KZA (ASX) to my watchlist

rikkiGreat posting for your fans on HC imoVery early in game -...

Top Stories

Ava Risk Group expands US presence with A$0.7M Substation Deal

Recce's R327 found effective against E.coli during clinical trial

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Microcap Wrap: 5 explorers with news out today

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Featured News